|
Volumn 143, Issue 2-3, 2013, Pages 393-394
|
Sleep-disordered breathing in schizophrenia: An audit
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
CHLORPROMAZINE;
HYPNOTIC AGENT;
NEUROLEPTIC AGENT;
SEDATIVE AGENT;
AGE;
AUSTRALIA;
BODY MASS;
DISEASE ASSOCIATION;
DRUG MEGADOSE;
FEMALE;
HIGH RISK PATIENT;
HOSPITAL PATIENT;
HUMAN;
LETTER;
LOW RISK POPULATION;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL AUDIT;
OBESITY;
PATIENT MONITORING;
PRIORITY JOURNAL;
RISK FACTOR;
SCHIZOPHRENIA;
SELF REPORT;
SIDE EFFECT;
SLEEP DISORDERED BREATHING;
SLEEP PATTERN;
SMOKING;
SNORING;
TEST RETEST RELIABILITY;
WEIGHT GAIN;
ADULT;
ANTIPSYCHOTIC AGENTS;
COMORBIDITY;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
RISK;
SCHIZOPHRENIA;
SLEEP APNEA SYNDROMES;
SLEEP APNEA, OBSTRUCTIVE;
|
EID: 84872369273
PISSN: 09209964
EISSN: 15732509
Source Type: Journal
DOI: 10.1016/j.schres.2012.11.034 Document Type: Letter |
Times cited : (9)
|
References (6)
|